PCM
Piermont Capital Management Portfolio holdings
AUM
$211M
1-Year Return
8.09%
This Quarter Return
+7.55%
1 Year Return
-8.09%
3 Year Return
+33.25%
5 Year Return
+53.21%
10 Year Return
–
AUM
$422M
AUM Growth
+$36.1M
(+9.3%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
10%
Holding
310
New
74
Increased
75
Reduced
64
Closed
65
Top Buys
| 1 |
AAR Corp
AIR
|
$3.64M |
| 2 |
Murphy USA
MUSA
|
$3.56M |
| 3 |
Interface
TILE
|
$3.31M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
$3.23M |
| 5 |
Spire
SR
|
$3.19M |
Top Sells
| 1 |
Allete
ALE
|
$3.98M |
| 2 |
Sanmina
SANM
|
$3.55M |
| 3 |
Portland General Electric
POR
|
$3.55M |
| 4 |
Trustmark
TRMK
|
$3.48M |
| 5 |
Northwest Natural Holdings
NWN
|
$3.37M |
Sector Composition
| 1 | Financials | 18.89% |
| 2 | Industrials | 16.55% |
| 3 | Consumer Discretionary | 12.85% |
| 4 | Technology | 12.66% |
| 5 | Real Estate | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIF
226
DELISTED
Tiffany & Co.
TIF
| $569K | 0.13% |
7,840
| – | – |
|
|
RGLS
227
DELISTED
Regulus Therapeutics
RGLS
| $548K | 0.13% |
1,384
+118
| +9% | +$46.7K |
|
|
PETX
228
DELISTED
Aratana Therapeutics, Inc.
PETX
| $541K | 0.13% |
+57,834
| New | +$541K |
|
229
Best Buy
BBY
$16.3B
| $539K | 0.13% |
14,110
| – | – |
|
230
Nektar Therapeutics
NKTR
$684M
| $534K | 0.13% |
2,072
-1,933
| -48% | -$498K |
|
|
IPXL
231
DELISTED
Impax Laboratories, Inc.
IPXL
| $534K | 0.13% |
+22,540
| New | +$534K |
|
|
TRVN
232
DELISTED
Trevena, Inc.
TRVN
| $529K | 0.13% |
+125
| New | +$529K |
|
233
Karyopharm Therapeutics
KPTI
$58.4M
| $507K | 0.12% |
+3,472
| New | +$507K |
|
234
Amphastar Pharmaceuticals
AMPH
$1.36B
| $506K | 0.12% |
+26,663
| New | +$506K |
|
235
Spirit AeroSystems
SPR
$4.84B
| $499K | 0.12% |
11,200
| – | – |
|
236
ANI Pharmaceuticals
ANIP
$2.08B
| $490K | 0.12% |
+7,380
| New | +$490K |
|
|
AKRX
237
DELISTED
Akorn, Inc.
AKRX
| $483K | 0.11% |
+17,730
| New | +$483K |
|
|
CBM
238
DELISTED
Cambrex Corporation
CBM
| $431K | 0.1% |
+9,690
| New | +$431K |
|
239
Fluor
FLR
$6.7B
| $430K | 0.1% |
8,380
| – | – |
|
240
Exelixis
EXEL
$10.1B
| $400K | 0.09% |
+31,270
| New | +$400K |
|
241
Steel Dynamics
STLD
$19.3B
| $382K | 0.09% |
15,270
| – | – |
|
|
ANDV
242
DELISTED
Andeavor
ANDV
| $368K | 0.09% |
4,630
| – | – |
|
243
Ameren
AEE
$27.3B
| $357K | 0.08% |
7,250
+1,600
| +28% | +$78.8K |
|
244
Novavax
NVAX
$1.27B
| $330K | 0.08% |
7,939
+668
| +9% | +$27.8K |
|
|
245
Allete
ALE
$3.7B
| – | – |
-61,581
| Closed | -$3.98M |
|
|
ALEX
246
Alexander & Baldwin
ALEX
$1.39B
| – | – |
-73,855
| Closed | -$2.67M |
|
247
ArcBest
ARCB
$1.69B
| – | – |
-97,740
| Closed | -$1.59M |
|
248
ATN International
ATNI
$254M
| – | – |
-16,147
| Closed | -$1.26M |
|
249
Werner Enterprises
WERN
$1.72B
| – | – |
-106,369
| Closed | -$2.44M |
|
250
American Axle
AXL
$710M
| – | – |
-41,187
| Closed | -$596K |
|